Cancer Immunotherapy

Other | May 1, 2006

byAllison, James, JAMES ALLISON

not yet rated|write a review
For some time immunotherapy has been heralded as a breakthrough approach for cancer treatment. Although the potential of this strategy remains solid, the approach needs considerable refinement. Whilst some programmes are looking to increase the understanding of molecular and cellular mechanisms underlying the stimulation of antitumor immunity, others are trying to find the most appropriate clinical setting that will reveal the role of the immune system in combating cancer. Among the most important discoveries have been tumor-specific antigens.

This thematic volume highlights some key issues and discusses where they may move forward. It has been put together by two leading cancer immunotherapists from two eminent institutions that focus on cancer research.

Pricing and Purchase Info

$207.19 online
$269.03 list price (save 22%)
In stock online
Ships free on orders over $25

From the Publisher

For some time immunotherapy has been heralded as a breakthrough approach for cancer treatment. Although the potential of this strategy remains solid, the approach needs considerable refinement. Whilst some programmes are looking to increase the understanding of molecular and cellular mechanisms underlying the stimulation of antitumor i...

Format:OtherDimensions:400 pages, 1 × 1 × 1 inPublished:May 1, 2006Publisher:Academic PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0080463371

ISBN - 13:9780080463377

Customer Reviews of Cancer Immunotherapy

Reviews

Extra Content

Table of Contents

Engineered cellular vaccines
Blockade of T cell checkpoints.
Serex in the identification of target antigens
New approaches to tumor immunotherapy
Melanoma antigens
Antibodies and chimeric molecules
Tumor Immunosurveillance
Dendritic Cells
Strategies for Tumor Vaccination
DNA vaccines